Centrus Energy ((LEU)) has held its Q1 earnings call. Read on for the main highlights of the call.
Meet Samuel – Your Personal Investing Prophet
Explore LEUX for 2X leverage on LEUCentrus Energy’s latest earnings call struck an overall optimistic tone despite mixed quarterly figures. Management emphasized a record $3.9 billion backlog, a major government HALEU contract, and nearly $2 billion in cash as pillars of long-term value. However, they also acknowledged pressure on near-term profitability from expansion spending and variable sales, leaving investors balancing opportunity with execution risk.
Revenue and Profitability in Q1 2026
Centrus reported Q1 revenue of $76.7 million, a 5% increase year over year, with gross profit of $31.5 million and operating income of $0.8 million. Net income came in at $10.0 million, or $0.45 per diluted share, while new adjusted metrics showed adjusted net income of $23.5 million and adjusted EPS of $1.05.
Stabilized View from Trailing Twelve Months
To smooth out quarter-to-quarter swings, the company highlighted trailing twelve-month revenue of $452.3 million and TTM net income of $60.6 million. On an adjusted basis, TTM net income reached $87.8 million, which management framed as a better barometer of underlying performance in a lumpy, contract-driven business.
Backlog Anchors Long-Term Visibility
Centrus underscored a $3.9 billion backlog stretching through 2040 as a key support for future revenue. This includes $3.1 billion tied to low-enriched uranium and $0.8 billion from Technical Solutions, offering investors a long runway of contracted demand across both core enrichment and services.
Major DOE HALEU Award and Production Ramp
A centerpiece of the call was a roughly $900 million HALEU enrichment award from the U.S. Department of Energy, which could exceed $1 billion depending on negotiations. Since launching the HALEU operations contract, Centrus has contractually produced more than 1.6 metric tons of HALEU UF6, underscoring tangible progress in this strategic market.
Strong Cash Position and Funding Flexibility
The company ended Q1 with $1.9 billion of unrestricted cash and chose not to tap its at-the-market program. Combined with milestone payments from the DOE HALEU award, management estimates about $2.8 billion of funding capacity, which they believe is sufficient to cover near-term capital needs without stressing the balance sheet.
Manufacturing Expansion and New Partnerships
Centrus has launched a $560 million investment in centrifuge manufacturing at Oak Ridge and announced three key partners: Fluor for engineering and construction, Palantir for data and optimization, and Geiger Brothers for on-the-ground building work. These initiatives are expected to unlock around $300 million in cost savings and shorter lead times as the build-out progresses.
Higher 2026 Revenue Outlook and Workforce Plans
Reflecting growing confidence, management raised 2026 revenue guidance to a range of $450 million to $500 million, up from prior expectations. They also reaffirmed targets for capital spending and project milestones while increasing hiring plans at both Oak Ridge and Piketon, signaling continued scaling of operations.
Technical Solutions and HALEU Drive Growth
Technical Solutions revenue climbed to $32.1 million in Q1, a 47% increase versus last year, fueled largely by the HALEU operations contract. Roughly $9.8 million of the segment’s growth came from HALEU-related work, positioning this business line as a key growth engine alongside traditional enrichment.
LEU Segment Weakness and SWU Volatility
The LEU segment saw revenue slip 13% to $44.6 million in the quarter, as separative work unit sales fell sharply. SWU volume dropped 47%, though this was partly offset by a 52% rise in average SWU pricing, underscoring how shipment timing and contract mix can drive significant quarterly volatility.
Declining GAAP Net Income and EPS
Despite higher revenue, GAAP profitability weakened year over year, with net income declining from $27.2 million to $10.0 million and diluted EPS falling from $1.60 to $0.45. Adjusted results also softened, as adjusted net income slipped from $28.6 million to $23.5 million and adjusted EPS from $1.68 to $1.05.
Expansion Costs Weigh on Near-Term Results
Advanced technology and growth-related expenses rose by $15.9 million in Q1, reflecting the company’s aggressive build-out strategy. Total capital-related spending reached $45.2 million, including $23.2 million of CapEx and $22.0 million of non-CapEx items such as a $5 million prepayment to Palantir, with management signaling that elevated costs will continue near term.
Gross Profit Impacted by Mix and Costs
Quarterly gross profit edged down to $31.5 million from $32.9 million a year ago despite improved SWU pricing. Management attributed the modest decline to an unfavorable mix shift and higher costs tied to the expansion, highlighting the transitional nature of current margins.
Execution and Procurement Timing Risks
While the DOE HALEU award and potential sole-source work are meaningful opportunities, management cautioned that terms and timing are still being finalized. With limited disclosure allowed during active procurement, investors face some uncertainty around when milestones will be met and how quickly associated funding and revenue will flow.
Reliance on Opportunistic Sales Model
Centrus reminded investors that uranium and SWU sales remain opportunistic, with no commitment to strict timing of deliveries. This model can produce sizable quarter-to-quarter swings in revenue and margins, making the trailing twelve-month view more informative than any single quarter’s results.
Forward Guidance and Strategic Roadmap
Looking ahead, Centrus reaffirmed its 2026 operational plan while boosting revenue guidance to $450 million to $500 million, backed by its $3.9 billion backlog and DOE HALEU milestones. The company plans to hold total capital spending to $350 million to $500 million, finalize contracts with all critical partners, deliver a certified-for-construction package, and expand headcount significantly at both Oak Ridge and Piketon.
Centrus’s earnings call painted a company in transition, trading short-term earnings pressure for a larger, more diversified business anchored by HALEU and advanced nuclear services. For investors, the story hinges on whether management can convert its sizable backlog, government awards, and partnerships into consistent cash flows while managing costs and execution risk during the build-out phase.